A monoclonal antibody produced against Naked2

Area of Science:

• Molecular Biology
• Cell Signaling
• Immunology

Background:

• Naked2 (NKD2) is a key regulator of canonical Wnt signaling.
• Dysregulation of Wnt signaling is implicated in embryonic development and tumor formation.
• Understanding NKD2's role requires specific tools for its detection and study.

Purpose of the Study:

• To establish a specific monoclonal antibody against Naked2 (NKD2).
• To validate the antibody's specificity and utility in detecting NKD2 protein.
• To provide a tool for further investigation of NKD2's biological functions.

Main Methods:

• Hybridoma technology for monoclonal antibody production.
• Indirect ELISA for antibody titration.
• Western blot, immunoprecipitation, and confocal microscopy for specificity validation.
• Competitive inhibition assays to confirm antibody binding site.

Main Results:

• A high-titer monoclonal antibody against NKD2 (anti-NKD2 MAb) was successfully generated.
• The anti-NKD2 MAb demonstrated specific binding to NKD2 protein in SW480 and LOVO cell lines.
• Antibody binding was confirmed to be specific to the NKD2 protein via competitive inhibition assays.

Conclusions:

• The developed anti-NKD2 MAb is a specific and valuable tool for NKD2 research.
• This antibody will facilitate studies on NKD2's structure-activity relationships.
• The antibody supports further investigation into NKD2's role in protein detection and Wnt signaling pathways.